Fusion Gene Studies
in Kim Lab

FusionBase FusionGDB FusionGDB2 FusionPDB FusionNeoAntigen FusionAI FusionNW FGviewer Publication Contact
FusionGDB Logo

Home

Download

Statistics

Examples

Help

Contact

Center for Computational Systems Medicine
leaf

Fusion Gene Summary

leaf

Fusion Gene ORF analysis

leaf

Fusion Genomic Features

leaf

Fusion Protein Features

leaf

Fusion Gene Sequence

leaf

Fusion Gene PPI analysis

leaf

Related Drugs

leaf

Related Diseases

Fusion gene:ASXL2-POMC (FusionGDB2 ID:HG55252TG5443)

Fusion Gene Summary for ASXL2-POMC

check button Fusion gene summary
Fusion gene informationFusion gene name: ASXL2-POMC
Fusion gene ID: hg55252tg5443
HgeneTgene
Gene symbol

ASXL2

POMC

Gene ID

55252

5443

Gene nameASXL transcriptional regulator 2proopiomelanocortin
SynonymsASXH2|SHAPNSACTH|CLIP|LPH|MSH|NPP|OBAIRH|POC
Cytomap('ASXL2')('POMC')

2p23.3

2p23.3

Type of geneprotein-codingprotein-coding
Descriptionputative Polycomb group protein ASXL2additional sex combs like 2, transcriptional regulatoradditional sex combs-like protein 2polycomb group protein ASXH2pro-opiomelanocortinadrenocorticotropic hormoneadrenocorticotropinalpha-MSHalpha-melanocyte-stimulating hormonebeta-LPHbeta-MSHbeta-endorphinbeta-melanocyte-stimulating hormonecorticotropin-like intermediary peptidecorticotropin-lipotropingamma
Modification date2020031320200322
UniProtAcc

Q76L83

.
Ensembl transtripts involved in fusion geneENST00000336112, ENST00000435504, 
ENST00000272341, ENST00000497092, 
ENST00000404843, 
Fusion gene scores* DoF score18 X 11 X 10=19802 X 1 X 2=4
# samples 242
** MAII scorelog2(24/1980*10)=-3.04439411935845
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(2/4*10)=2.32192809488736
Context

PubMed: ASXL2 [Title/Abstract] AND POMC [Title/Abstract] AND fusion [Title/Abstract]

Most frequent breakpointASXL2(26022254)-POMC(25387661), # samples:1
Anticipated loss of major functional domain due to fusion event.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
HgeneASXL2

GO:0035360

positive regulation of peroxisome proliferator activated receptor signaling pathway

21047783

HgeneASXL2

GO:0045600

positive regulation of fat cell differentiation

21047783

HgeneASXL2

GO:0045944

positive regulation of transcription by RNA polymerase II

21047783

TgenePOMC

GO:0032720

negative regulation of tumor necrosis factor production

10233018

TgenePOMC

GO:0045944

positive regulation of transcription by RNA polymerase II

18292087



check button Fusion gene information
* All genome coordinats were lifted-over on hg19.
* Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser.
SourceDiseaseSampleHgeneHchrHbpHstrandTgeneTchrTbpTstrand
ChimerDB4PRADTCGA-KK-A7B2-01AASXL2chr2

26022254

-POMCchr2

25387661

-


Top

Fusion Gene ORF analysis for ASXL2-POMC

check button Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure.
* Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser.
ORFHenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrand
5CDS-5UTRENST00000336112ENST00000264708ASXL2chr2

26022254

-POMCchr2

25387661

-
5CDS-5UTRENST00000336112ENST00000380794ASXL2chr2

26022254

-POMCchr2

25387661

-
5CDS-5UTRENST00000336112ENST00000395826ASXL2chr2

26022254

-POMCchr2

25387661

-
5CDS-5UTRENST00000336112ENST00000405623ASXL2chr2

26022254

-POMCchr2

25387661

-
5CDS-5UTRENST00000435504ENST00000264708ASXL2chr2

26022254

-POMCchr2

25387661

-
5CDS-5UTRENST00000435504ENST00000380794ASXL2chr2

26022254

-POMCchr2

25387661

-
5CDS-5UTRENST00000435504ENST00000395826ASXL2chr2

26022254

-POMCchr2

25387661

-
5CDS-5UTRENST00000435504ENST00000405623ASXL2chr2

26022254

-POMCchr2

25387661

-
5UTR-5UTRENST00000272341ENST00000264708ASXL2chr2

26022254

-POMCchr2

25387661

-
5UTR-5UTRENST00000272341ENST00000380794ASXL2chr2

26022254

-POMCchr2

25387661

-
5UTR-5UTRENST00000272341ENST00000395826ASXL2chr2

26022254

-POMCchr2

25387661

-
5UTR-5UTRENST00000272341ENST00000405623ASXL2chr2

26022254

-POMCchr2

25387661

-
5UTR-5UTRENST00000497092ENST00000264708ASXL2chr2

26022254

-POMCchr2

25387661

-
5UTR-5UTRENST00000497092ENST00000380794ASXL2chr2

26022254

-POMCchr2

25387661

-
5UTR-5UTRENST00000497092ENST00000395826ASXL2chr2

26022254

-POMCchr2

25387661

-
5UTR-5UTRENST00000497092ENST00000405623ASXL2chr2

26022254

-POMCchr2

25387661

-
intron-5UTRENST00000404843ENST00000264708ASXL2chr2

26022254

-POMCchr2

25387661

-
intron-5UTRENST00000404843ENST00000380794ASXL2chr2

26022254

-POMCchr2

25387661

-
intron-5UTRENST00000404843ENST00000395826ASXL2chr2

26022254

-POMCchr2

25387661

-
intron-5UTRENST00000404843ENST00000405623ASXL2chr2

26022254

-POMCchr2

25387661

-

check buttonORFfinder result based on the fusion transcript sequence of in-frame fusion genes.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score

Top

Fusion Genomic Features for ASXL2-POMC


check buttonFusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints.
HgeneHchrHbpHstrandTgeneTchrTbpTstrand1-pp (fusion gene breakpoint)


Top

Fusion Protein Features for ASXL2-POMC


check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/:26022254/:25387661)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonMain function of each fusion partner protein. (from UniProt)
HgeneTgene
ASXL2

Q76L83

.
FUNCTION: Putative Polycomb group (PcG) protein. PcG proteins act by forming multiprotein complexes, which are required to maintain the transcriptionally repressive state of homeotic genes throughout development. PcG proteins are not required to initiate repression, but to maintain it during later stages of development. They probably act via methylation of histones, rendering chromatin heritably changed in its expressibility (By similarity). Involved in transcriptional regulation mediated by ligand-bound nuclear hormone receptors, such as peroxisome proliferator-activated receptor gamma (PPARG). Acts as coactivator for PPARG and enhances its adipocyte differentiation-inducing activity; the function seems to involve differential recruitment of acetylated and methylated histone H3. {ECO:0000250, ECO:0000269|PubMed:21047783}.FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at

download page


* Minus value of BPloci means that the break pointn is located before the CDS.
- In-frame and retained protein feature among the 13 regional features.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

- In-frame and not-retained protein feature among the 13 regional features.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note


Top

Fusion Gene Sequence for ASXL2-POMC


check button For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones.

Top

Fusion Gene PPI Analysis for ASXL2-POMC


check button Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in

ChiPPI page.


check button Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160)
HgeneHgene's interactorsTgeneTgene's interactors


check button - Retained PPIs in in-frame fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenStill interaction with


check button - Lost PPIs in in-frame fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenInteraction lost with


check button - Retained PPIs, but lost function due to frame-shift fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenInteraction lost with


Top

Related Drugs for ASXL2-POMC


check button Drugs targeting genes involved in this fusion gene.
(DrugBank Version 5.1.8 2021-05-08)
PartnerGeneUniProtAccDrugBank IDDrug nameDrug activityDrug typeDrug status

Top

Related Diseases for ASXL2-POMC


check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource
HgeneASXL2C0005684Malignant neoplasm of urinary bladder1CTD_human
HgeneASXL2C0005695Bladder Neoplasm1CTD_human
HgeneASXL2C0023467Leukemia, Myelocytic, Acute1CTD_human
HgeneASXL2C0026998Acute Myeloid Leukemia, M11CTD_human
HgeneASXL2C1879321Acute Myeloid Leukemia (AML-M2)1CTD_human
HgeneASXL2C4310672SHASHI-PENA SYNDROME1GENOMICS_ENGLAND
TgeneC0020538Hypertensive disease68CTD_human
TgeneC0037769West Syndrome20CTD_human
TgeneC0393698Cryptogenic Infantile Spasms20CTD_human
TgeneC0393699Symptomatic Infantile Spasms20CTD_human
TgeneC0546878Nodding spasm20CTD_human
TgeneC0553558Jackknife Seizures20CTD_human
TgeneC0684276Hypsarrhythmia20CTD_human
TgeneC1527306spasmus nutans20CTD_human
TgeneC1527366Salaam Seizures20CTD_human
TgeneC0020621Hypokalemia9CTD_human
TgeneC0011581Depressive disorder6CTD_human;PSYGENET
TgeneC0018800Cardiomegaly6CTD_human
TgeneC0022333Jacksonian Seizure6CTD_human
TgeneC0036572Seizures6CTD_human
TgeneC0149958Complex partial seizures6CTD_human
TgeneC0234533Generalized seizures6CTD_human
TgeneC0234535Clonic Seizures6CTD_human
TgeneC0270824Visual seizure6CTD_human
TgeneC0270844Tonic Seizures6CTD_human
TgeneC0270846Epileptic drop attack6CTD_human
TgeneC0422850Seizures, Somatosensory6CTD_human
TgeneC0422852Seizures, Auditory6CTD_human
TgeneC0422853Olfactory seizure6CTD_human
TgeneC0422854Gustatory seizure6CTD_human
TgeneC0422855Vertiginous seizure6CTD_human
TgeneC0494475Tonic - clonic seizures6CTD_human
TgeneC0751056Non-epileptic convulsion6CTD_human
TgeneC0751110Single Seizure6CTD_human
TgeneC0751123Atonic Absence Seizures6CTD_human
TgeneC0751494Convulsive Seizures6CTD_human
TgeneC0751495Seizures, Focal6CTD_human
TgeneC0751496Seizures, Sensory6CTD_human
TgeneC1383860Cardiac Hypertrophy6CTD_human
TgeneC3495874Nonepileptic Seizures6CTD_human
TgeneC4048158Convulsions6CTD_human
TgeneC4316903Absence Seizures6CTD_human
TgeneC4317109Epileptic Seizures6CTD_human
TgeneC4317123Myoclonic Seizures6CTD_human
TgeneC4505436Generalized Absence Seizures6CTD_human
TgeneC0001787Osteoporosis, Age-Related5CTD_human
TgeneC0001973Alcoholic Intoxication, Chronic5PSYGENET
TgeneC0007194Hypertrophic Cardiomyopathy5CTD_human
TgeneC0011570Mental Depression5PSYGENET
TgeneC0029456Osteoporosis5CTD_human
TgeneC0029459Osteoporosis, Senile5CTD_human
TgeneC0751406Post-Traumatic Osteoporosis5CTD_human
TgeneC4551472Hypertrophic obstructive cardiomyopathy5CTD_human
TgeneC0001231ACTH Syndrome, Ectopic4CTD_human
TgeneC0009171Cocaine Abuse4CTD_human
TgeneC0020649Hypotension4CTD_human
TgeneC0038587Substance Withdrawal Syndrome4CTD_human
TgeneC0086189Drug Withdrawal Symptoms4CTD_human
TgeneC0087169Withdrawal Symptoms4CTD_human
TgeneC0236736Cocaine-Related Disorders4CTD_human
TgeneC0600427Cocaine Dependence4CTD_human
TgeneC0005586Bipolar Disorder3CTD_human;PSYGENET
TgeneC0013604Edema3CTD_human
TgeneC0030193Pain3CTD_human
TgeneC0030846Penile Diseases3CTD_human
TgeneC0085762Alcohol abuse3PSYGENET
TgeneC0151603Anasarca3CTD_human
TgeneC0234230Pain, Burning3CTD_human
TgeneC0234238Ache3CTD_human
TgeneC0234254Radiating pain3CTD_human
TgeneC0428977Bradycardia3CTD_human
TgeneC0458257Pain, Splitting3CTD_human
TgeneC0458259Pain, Crushing3CTD_human
TgeneC0751407Pain, Migratory3CTD_human
TgeneC0751408Suffering, Physical3CTD_human
TgeneC0003129Anoxemia2CTD_human
TgeneC0003130Anoxia2CTD_human
TgeneC0005587Depression, Bipolar2CTD_human
TgeneC0007370Catalepsy2CTD_human
TgeneC0010481Cushing Syndrome2CTD_human
TgeneC0017658Glomerulonephritis2CTD_human
TgeneC0018801Heart failure2CTD_human
TgeneC0018802Congestive heart failure2CTD_human
TgeneC0018965Hematuria2CTD_human
TgeneC0019080Hemorrhage2CTD_human
TgeneC0020438Hypercalciuria2CTD_human
TgeneC0020488Hypernatremia2CTD_human
TgeneC0022672Acute Kidney Tubular Necrosis2CTD_human
TgeneC0023212Left-Sided Heart Failure2CTD_human
TgeneC0023893Liver Cirrhosis, Experimental2CTD_human
TgeneC0024713Manic Disorder2CTD_human
TgeneC0026769Multiple Sclerosis2CTD_human
TgeneC0028754Obesity2CTD_human;GENOMICS_ENGLAND
TgeneC0043094Weight Gain2CTD_human
TgeneC0233612Waxy flexibility2CTD_human
TgeneC0235527Heart Failure, Right-Sided2CTD_human
TgeneC0242184Hypoxia2CTD_human
TgeneC0338831Manic2CTD_human
TgeneC0700292Hypoxemia2CTD_human
TgeneC0751324Multiple Sclerosis, Acute Fulminating2CTD_human
TgeneC1262477Weight decreased2CTD_human
TgeneC1704377Bright Disease2CTD_human
TgeneC1959583Myocardial Failure2CTD_human
TgeneC1961112Heart Decompensation2CTD_human
TgeneC3714514Infection2CTD_human
TgeneC0001614Adrenal Cortex Diseases1CTD_human
TgeneC0002622Amnesia1CTD_human
TgeneC0003868Arthritis, Gouty1CTD_human
TgeneC0004352Autistic Disorder1CTD_human
TgeneC0004930Behavior Disorders1CTD_human
TgeneC0004936Mental disorders1CTD_human
TgeneC0005910Body Weight1CTD_human
TgeneC0006663Calcinosis1CTD_human
TgeneC0007134Renal Cell Carcinoma1CTD_human
TgeneC0007789Cerebral Palsy1CTD_human
TgeneC0008370Cholestasis1CTD_human
TgeneC0009806Constipation1CTD_human
TgeneC0010692Cystitis1CTD_human
TgeneC0011573Endogenous depression1CTD_human
TgeneC0011848Diabetes Insipidus1CTD_human
TgeneC0011849Diabetes Mellitus1CTD_human
TgeneC0014544Epilepsy1CTD_human
TgeneC0014549Tonic-Clonic Epilepsy1CTD_human
TgeneC0014550Myoclonic Epilepsy1CTD_human
TgeneC0015397Disorder of eye1CTD_human
TgeneC0015469Facial paralysis1CTD_human
TgeneC0015695Fatty Liver1CTD_human
TgeneC0015814Femur Head Necrosis1CTD_human
TgeneC0015967Fever1CTD_human
TgeneC0017178Gastrointestinal Diseases1CTD_human
TgeneC0019337Heroin Dependence1CTD_human
TgeneC0019572Hirsutism1CTD_human
TgeneC0020598Hypocalcemia1CTD_human
TgeneC0021053Immune System Diseases1CTD_human
TgeneC0022650Kidney Calculi1CTD_human
TgeneC0022658Kidney Diseases1CTD_human
TgeneC0022660Kidney Failure, Acute1CTD_human
TgeneC0023882Little's Disease1CTD_human
TgeneC0023976Long QT Syndrome1CTD_human
TgeneC0025193Melancholia1CTD_human
TgeneC0025202melanoma1CTD_human
TgeneC0026896Myasthenia Gravis1CTD_human
TgeneC0027497Nausea1CTD_human
TgeneC0027540Necrosis1CTD_human
TgeneC0027709Nephrocalcinosis1CTD_human
TgeneC0028961Oliguria1CTD_human
TgeneC0030286Pancreatic Diseases1CTD_human
TgeneC0032285Pneumonia1CTD_human
TgeneC0032300Lobar Pneumonia1CTD_human
TgeneC0032787Postoperative Complications1CTD_human
TgeneC0033141Cardiomyopathies, Primary1CTD_human
TgeneC0033687Proteinuria1CTD_human
TgeneC0035258Restless Legs Syndrome1CTD_human
TgeneC0035411Rhabdomyoma1CTD_human
TgeneC0036529Myocardial Diseases, Secondary1CTD_human
TgeneC0037052Sick Sinus Syndrome1CTD_human
TgeneC0039103Synovitis1CTD_human
TgeneC0041696Unipolar Depression1CTD_human
TgeneC0042029Urinary tract infection1CTD_human
TgeneC0086133Depressive Syndrome1CTD_human
TgeneC0086237Epilepsy, Cryptogenic1CTD_human
TgeneC0151744Myocardial Ischemia1CTD_human
TgeneC0151827Eye pain1CTD_human
TgeneC0154695Diplegic Infantile Cerebral Palsy1CTD_human
TgeneC0154697Cerebral Palsy, Quadriplegic, Infantile1CTD_human
TgeneC0154698Monoplegic Infantile Cerebral Palsy1CTD_human
TgeneC0162557Liver Failure, Acute1CTD_human
TgeneC0221406Pituitary-dependent Cushing's disease1CTD_human
TgeneC0233750Hysterical amnesia1CTD_human
TgeneC0233796Temporary Amnesia1CTD_human
TgeneC0236018Aura1CTD_human
TgeneC0236795Dissociative Amnesia1CTD_human
TgeneC0237326Dyschezia1CTD_human
TgeneC0242217Calcium Pyrophosphate Dihydrate Deposition1CTD_human
TgeneC0262497Global Amnesia1CTD_human
TgeneC0263628Tumoral calcinosis1CTD_human
TgeneC0270742Athetoid cerebral palsy1CTD_human
TgeneC0270807Monoplegic Cerebral Palsy1CTD_human
TgeneC0279702Conventional (Clear Cell) Renal Cell Carcinoma1CTD_human
TgeneC0282126Depression, Neurotic1CTD_human
TgeneC0338478Idiopathic Myoclonic Epilepsy1CTD_human
TgeneC0338479Symptomatic Myoclonic Epilepsy1CTD_human
TgeneC0338596Spastic cerebral palsy1CTD_human
TgeneC0340375Subaortic stenosis1CTD_human
TgeneC0376338Diagnosis, Psychiatric1CTD_human
TgeneC0393626Opsoclonus-Myoclonus Syndrome1CTD_human
TgeneC0393695Early Childhood Epilepsy, Myoclonic1CTD_human
TgeneC0393702Myoclonic Astatic Epilepsy1CTD_human
TgeneC0393703Myoclonic Absence Epilepsy1CTD_human
TgeneC0394003Cerebral Palsy, Dystonic-Rigid1CTD_human
TgeneC0394007Cerebral Palsy, Atonic1CTD_human
TgeneC0410480Avascular Necrosis of Femur Head1CTD_human
TgeneC0410574Synovial Hypertrophy1CTD_human
TgeneC0427055Facial Paresis1CTD_human
TgeneC0428908Sinus Node Dysfunction (disorder)1CTD_human
TgeneC0438414Myoclonic Encephalopathy1CTD_human
TgeneC0521174Microcalcification1CTD_human
TgeneC0524595Aseptic Necrosis of Femur Head1CTD_human
TgeneC0553730Calcium pyrophosphate deposition disease1CTD_human
TgeneC0553767Congenital Cerebral Palsy1CTD_human
TgeneC0559031Functional Gastrointestinal Disorders1CTD_human
TgeneC0574960Sacroiliitis1CTD_human
TgeneC0600241heroin abuse1CTD_human
TgeneC0600467Neurogenic Inflammation1CTD_human
TgeneC0750906Tactile Amnesia1CTD_human
TgeneC0750907Amnestic State1CTD_human
TgeneC0751024Cerebral Palsy, Mixed1CTD_human
TgeneC0751025Cerebral Palsy, Rolandic Type1CTD_human
TgeneC0751111Awakening Epilepsy1CTD_human
TgeneC0751117Cryptogenic Tonic-Clonic Epilepsy1CTD_human
TgeneC0751118Epilepsy, Tonic-Clonic, Familial1CTD_human
TgeneC0751119Epilepsy, Tonic-Clonic, Symptomatic1CTD_human
TgeneC0751120Benign Infantile Myoclonic Epilepsy1CTD_human
TgeneC0751122Infantile Severe Myoclonic Epilepsy1CTD_human
TgeneC0751141Facial Palsy, Upper Motor Neuron1CTD_human
TgeneC0751142Facial Palsy, Lower Motor Neuron1CTD_human
TgeneC0751143Hemifacial Paralysis1CTD_human
TgeneC0751220Inappropriate ACTH Secretion Syndrome1CTD_human
TgeneC0751339Myasthenia Gravis, Generalized1CTD_human
TgeneC0751340Myasthenia Gravis, Ocular1CTD_human
TgeneC0751508Long Sleeper Syndrome1CTD_human
TgeneC0751509Short Sleeper Syndrome1CTD_human
TgeneC0751510Sleep-Related Neurogenic Tachypnea1CTD_human
TgeneC0751511Subwakefullness Syndrome1CTD_human
TgeneC0851578Sleep Disorders1CTD_human
TgeneC0878544Cardiomyopathies1CTD_human
TgeneC0887898Experimental Lung Inflammation1CTD_human
TgeneC0917800Epilepsy, Myoclonic, Infantile1CTD_human
TgeneC1096154Kinsbourne Syndrome1CTD_human
TgeneC1257861Colonic Inertia1CTD_human
TgeneC1266042Chromophobe Renal Cell Carcinoma1CTD_human
TgeneC1266043Sarcomatoid Renal Cell Carcinoma1CTD_human
TgeneC1266044Collecting Duct Carcinoma of the Kidney1CTD_human
TgeneC1306837Papillary Renal Cell Carcinoma1CTD_human
TgeneC1565321Cholera Infantum1CTD_human
TgeneC1565662Acute Kidney Insufficiency1CTD_human
TgeneC1721017Paraneoplastic Opsoclonus-Myoclonus Ataxia1CTD_human
TgeneC2609414Acute kidney injury1CTD_human
TgeneC2711227Steatohepatitis1CTD_human
TgeneC2936444Pyogenic Sacroiliitis1CTD_human
TgeneC2936445Septic Sacroiliitis1CTD_human
TgeneC2937358Cerebral Hemorrhage1CTD_human
TgeneC3714636Pneumonitis1CTD_human
TgeneC4042891Sleep Wake Disorders1CTD_human
TgeneC4046029Mental Disorders, Severe1CTD_human
TgeneC4505390Heroin Smoking1CTD_human